These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12097148)

  • 1. A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline Characteristics.
    Ford I; Blauw GJ; Murphy MB; Shepherd J; Cobbe SM; Bollen EL; Buckley BM; Jukema JW; Hyland M; Gaw A; Lagaay AM; Perry IJ; Macfarlane P; Norrie J; Meinders AE; Sweeney BJ; Packard CJ; Westendorp RG; Twomey C; Stott DJ;
    Curr Control Trials Cardiovasc Med; 2002 May; 3(1):8. PubMed ID: 12097148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.
    Shepherd J; Blauw GJ; Murphy MB; Bollen EL; Buckley BM; Cobbe SM; Ford I; Gaw A; Hyland M; Jukema JW; Kamper AM; Macfarlane PW; Meinders AE; Norrie J; Packard CJ; Perry IJ; Stott DJ; Sweeney BJ; Twomey C; Westendorp RG;
    Lancet; 2002 Nov; 360(9346):1623-30. PubMed ID: 12457784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk.
    Shepherd J; Blauw GJ; Murphy MB; Cobbe SM; Bollen EL; Buckley BM; Ford I; Jukema JW; Hyland M; Gaw A; Lagaay AM; Perry IJ; Macfarlane PW; Meinders AE; Sweeney BJ; Packard CJ; Westendorp RG; Twomey C; Stott DJ
    Am J Cardiol; 1999 Nov; 84(10):1192-7. PubMed ID: 10569329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening experience and baseline characteristics in the West of Scotland Coronary Prevention Study. The WOSCOPS Study Group. West of Scotland Coronary Prevention Study.
    Am J Cardiol; 1995 Sep; 76(7):485-91. PubMed ID: 7653449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of statin treatment in elderly people: extended follow-up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER).
    Lloyd SM; Stott DJ; de Craen AJ; Kearney PM; Sattar N; Perry I; Packard CJ; Briggs A; Marchbank L; Comber H; Jukema JW; Westendorp RG; Trompet S; Buckley BM; Ford I
    PLoS One; 2013; 8(9):e72642. PubMed ID: 24023757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER).
    Freeman DJ; Robertson M; Brown EA; Rumley A; Tobias ES; Frölich M; Slagboom PE; Jukema JW; de Craen AJ; Sattar N; Ford I; Gaw A; Greer IA; Lowe GD; Stott DJ
    BMC Geriatr; 2011 Feb; 11():8. PubMed ID: 21342490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring the cost-effectiveness of lipid-lowering drugs in the elderly: the outcomes research and economic analysis components of the PROSPER trial.
    Avorn J; Benner J; Ford I; Ganz DA; Gaw A; Glynn RJ; Jackson J; Lagaay AM; Schneeweiss S; Walley T; Wang PS;
    Control Clin Trials; 2002 Dec; 23(6):757-73. PubMed ID: 12505250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The PROSPER Study (PROspective study of pravastatin in the elderly at risk)].
    Kulbertus H; Scheen AJ
    Rev Med Liege; 2002 Dec; 57(12):809-13. PubMed ID: 12632840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER).
    Sattar N; Murray HM; McConnachie A; Blauw GJ; Bollen EL; Buckley BM; Cobbe SM; Ford I; Gaw A; Hyland M; Jukema JW; Kamper AM; Macfarlane PW; Murphy MB; Packard CJ; Perry IJ; Stott DJ; Sweeney BJ; Twomey C; Westendorp RG; Shepherd J;
    Circulation; 2007 Feb; 115(8):981-9. PubMed ID: 17283264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anatomy of a clinical trial. The West of Scotland Coronary Prevention Study.
    Shepherd J; Gaw A;
    Med Princ Pract; 2002; 11 Suppl 2():17-30. PubMed ID: 12444307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing the next event in the elderly: the PROSPER perspective.
    Shepherd J
    Atheroscler Suppl; 2003 Dec; 4(5):17-22. PubMed ID: 14980231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins for the prevention of dementia.
    McGuinness B; Craig D; Bullock R; Passmore P
    Cochrane Database Syst Rev; 2009 Apr; (2):CD003160. PubMed ID: 19370582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up.
    LIPID Study Group (Long-term Intervention with Pravastatin in Ischaemic Disease)
    Lancet; 2002 Apr; 359(9315):1379-87. PubMed ID: 11978335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER).
    Packard CJ; Ford I; Robertson M; Shepherd J; Blauw GJ; Murphy MB; Bollen EL; Buckley BM; Cobbe SM; Gaw A; Hyland M; Jukema JW; Kamper AM; Macfarlane PW; Perry IJ; Stott DJ; Sweeney BJ; Twomey C; Westendorp RG;
    Circulation; 2005 Nov; 112(20):3058-65. PubMed ID: 16275871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin therapy in the elderly: does it make good clinical and economic sense?
    Mungall MM; Gaw A; Shepherd J
    Drugs Aging; 2003; 20(4):263-75. PubMed ID: 12641482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials.
    Lancet; 1996 Nov; 348(9038):1339-42. PubMed ID: 8918276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, rational, and baseline characteristics of the Prospective Pravastatin Pooling (PPP) project--a combined analysis of three large-scale randomized trials: Long-term Intervention with Pravastatin in Ischemic Disease (LIPID), Cholesterol and Recurrent Events (CARE), and West of Scotland Coronary Prevention Study (WOSCOPS).
    Am J Cardiol; 1995 Nov; 76(12):899-905. PubMed ID: 7484829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pravastatin: a review of its use in elderly patients.
    Bang LM; Goa KL
    Drugs Aging; 2003; 20(14):1061-82. PubMed ID: 14651445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.
    Vallejo-Vaz AJ; Robertson M; Catapano AL; Watts GF; Kastelein JJ; Packard CJ; Ford I; Ray KK
    Circulation; 2017 Nov; 136(20):1878-1891. PubMed ID: 28877913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial.
    Lewis SJ; Sacks FM; Mitchell JS; East C; Glasser S; Kell S; Letterer R; Limacher M; Moye LA; Rouleau JL; Pfeffer MA; Braunwald E
    J Am Coll Cardiol; 1998 Jul; 32(1):140-6. PubMed ID: 9669262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.